US2016237073A1PendingUtilityA1

Novel Polymorphs and Salts

Assignee: GLAXO GROUP LTDPriority: Sep 8, 2010Filed: Apr 26, 2016Published: Aug 18, 2016

Est. expirySep 8, 2030(~4.1 yrs left)· nominal 20-yr term from priority

Inventors:Julie Nicole Hamblin Paul Jones Suzanne Elaine Keeling Joelle Le Charlotte Jane Mitchell Nigel James Parr Robert David Willacy

C07D 413/14

PatentIndex Score

Cited by

References

Claims

Abstract

The present invention is directed to novel polymorphs and salts of a compound which is an inhibitor of kinase activity.

Claims

exact text as granted — not AI-modified

What is claimed is: 
     
         1 - 15 . (canceled) 
     
     
         16 . A salt of N-[5-[4-(5-{[(2R,6S)-2,6-dimethyl-4-morpholinyl]methyl}-1,3-oxazol-2-yl)-1H-indazol-6-yl]-2-(methyloxy)-3-pyridinyl]methanesulfonamide which is selected from the group consisting of from sodium, tosylate, maleate, hemi pamoate, hemi naphthalenedisulfonate, mesitylenesulfonate, hemi biphenyldisulfonate, 2-naphthalenesulfonate (napsylate), hemi cinnamate, hemi sebacate, hemi pyromellitate and hemi benzenediacrylate. 
     
     
         17 . A pharmaceutical composition comprising a salt according to  claim 16  and one or more pharmaceutically acceptable excipients.

Join the waitlist — get patent alerts

Track US2016237073A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.